Semaglutide targets the GLP-1 receptor, while Tirzepatide targets both GLP-1 and GIP receptors
Check with your plan administrator to confirm weight loss medications qualify under your specific plan
This creates a direct timing conflict with levothyroxine
And the future isnt looking all that great, either experts predict that, by 2030, nearly half of adults will have obesity
Any consideration of GLP-1 therapy for binge eating should occur within a multidisciplinary framework , ideally involving input from psychiatry, dietetics, and specialist weight management services, with psychological support remaining central to treatment
Caregivers or patients should be trained on proper injection techniques and should read the instructions for use